Occudo Quantitative Strategies LP Vbi Vaccines Inc Transaction History

Occudo Quantitative Strategies LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$2.8 - $3.72 $273,050 - $362,766	-97,518 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$2.61 - $4.17 $184,513 - $294,798	70,695 Added 263.56%	97,518 $327,000
Q1 2021 May 14, 2021	BUY	$2.91 - $4.32 $78,054 - $115,875	26,823 New	26,823 $83,000

688K

Ticker VBIV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 258,256,992
Market Cap $5.17M
Description
VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The...

Get notified when there are updates to the investment portfolio of Occudo Quantitative Strategies LP, based on Form 13F filings with the SEC.

Stay updated on Occudo Quantitative Strategies LP with notifications on news.